Core Viewpoint - DSS, Inc. has successfully closed a public offering, raising approximately $1.0 million in gross proceeds, which will be used for general corporate purposes including working capital [1][2]. Group 1: Offering Details - The public offering consisted of 900,000 shares of common stock priced at $1.00 per share [2]. - An overallotment option was granted to the underwriter, Aegis Capital Corp., allowing the purchase of an additional 135,000 shares, representing 15% of the shares sold in the offering [2]. - Aegis Capital Corp. served as the sole book-running manager for the offering [3]. Group 2: Regulatory Information - The offering was conducted under an effective shelf registration statement on Form S-3, previously filed with the SEC on October 31, 2024, and declared effective on November 5, 2024 [3]. Group 3: Company Overview - DSS, Inc. operates across multiple industries, including product packaging, biotechnology, commercial lending, and securities and investment management [5]. - The company focuses on developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings [5].

Core Viewpoint - DSS, Inc. has announced a public offering of common stock expected to generate approximately $1.0 million in gross proceeds, aimed at supporting general corporate purposes and working capital [1][3]. Group 1: Offering Details - The offering consists of 900,000 shares of common stock priced at $1.00 per share [2]. - If the underwriter's overallotment option for an additional 135,000 shares is fully exercised, total gross proceeds could reach approximately $1.035 million [3]. - The transaction is anticipated to close on or about February 5, 2026, pending customary closing conditions [3]. Group 2: Underwriting and Legal Counsel - Aegis Capital Corp. is serving as the sole book-running manager for the offering [4]. - Sichenzia Ross Ference Carmel LLP is acting as legal counsel for the Company, while Kaufman & Canoles, P.C. is counsel for Aegis Capital Corp [4]. Group 3: Company Overview - DSS, Inc. operates in multiple sectors including product packaging, biotechnology, commercial lending, and securities and investment management [7]. - The Company focuses on developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings [7].